Literature DB >> 6803830

Purification and properties of an aminoglycoside acetyltransferase from Pseudomonas aeruginosa.

R G Coombe, A M George.   

Abstract

An aminoglycoside 3-acetyltransferase [AAC(3)], possibly a new isoenzymic species of the 3-N-acetyltransferase group, was purified to apparent homogeneity from a crude extract of Pseudomonas aeruginosa, a gentamicin-resistant clinical isolate. The method of purification was consecutive column chromatography--(i) gel filtration, (ii) affinity chromatography, and (iii) ion-exchange chromatography--to give two protein peaks, one of which was coincident with activity and which indicated a purification of 600 (specific activity = 9.743 units mg-1 at pH 7.2, 34 degrees C). Polyacrylamide disc gel electrophoresis indicated a single protein band coincident with enzymic activity. The molecular weight of the enzyme was about 39 000. AAC(3)-V (provisonal designation) was further characterized by stability, substrate, pH, and kinetic studies. The Km was 0.724 microM (sisomicin), and the Vmax was 0.102 mumol min-1 mg-1 (sisomicin) at pH 7.2 and 34 degrees C. Substrate inhibition was exhibited by kanamycin A and tobramycin. Studies showed that enzyme activity was significantly stabilized when preparations contained substrate.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6803830     DOI: 10.1021/bi00534a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  3 in total

1.  The kinetic mechanism of AAC3-IV aminoglycoside acetyltransferase from Escherichia coli.

Authors:  Maria L B Magalhaes; John S Blanchard
Journal:  Biochemistry       Date:  2005-12-13       Impact factor: 3.162

2.  Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases.

Authors:  A Fernandez-Rodriguez; R Canton; J C Perez-Diaz; J Martinez-Beltran; J J Picazo; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

3.  Appearance of amikacin and tobramycin resistance due to 4'-aminoglycoside nucleotidyltransferase [ANT(4')-II] in gram-negative pathogens.

Authors:  G A Jacoby; M J Blaser; P Santanam; H Hächler; F H Kayser; R S Hare; G H Miller
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.